SI
Sintx Technologies, Inc.
SINT · NASDAQ
$1.73 +6.13% (+$0.10)
1M +13.07%
Market Cap $10.4M
P/E Ratio -
Div. Yield -
ROE 565.55%
Bulios Fair Price
$1.51
12.7% downside
Current Price
$1.73
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SINT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
47 /100
Fair P/S 7.55x
P/B 2.16x
P/E N/A
Growth
78 /100
Growing Rev. growth 19.20%
Book val. growth 19.92%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 4.63%
Net margin 1,303.40%
Op. margin 852.14%
Quality
2 /100
Poor ROIC 238.32%
ROE 565.55%
ROA 172.58%
Debt
57 /100
Moderate Debt/Equity 0.63x
Current ratio 2.36x
Int. coverage -288.26x
Stability
50 /100
Moderate Beta 0.64x
Rev. volatility 215.77%
EPS volatility 22.72%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SINT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Eric K. Olson
Employees
32
Headquarters
Salt Lake City
Upcoming events
11 NOV
Earnings
Upcoming earnings report